Jeff Cislini, General Counsel at Revolution Medicines, Inc. (RVMD), sold 4,753 shares at $99.48 ($470K) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Scheduled sale ($470k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.48 | 1,795 | $179K | 38.0% |
| 2 | $99.48 | 1,795 | $179K | 38.0% |
| 3 | $97.44 | 1,163 | $113K | 24.1% |
| Total | $98.98 avg | 4,753 | $470K | 100% |
| Filing → |
| RVMD | SELL | 2026-08-25 | $11.9M | — | Filing → |
| RVMD | SELL | 2026-06-18 | $337K | — | Filing → |
| RVMD | SELL | 2026-01-23 | $105K | — | Filing → |